SDC1 and cancer: Thus, although these molecules serve as separate targets, our data suggest interactions between COL1A1-SDC1, COL6A2-SDC1, and COL6A3-SDC1 may serve as a target for therapeutic intervention in pan-cancer by intervention in the binding sites of two molecules.